Identification of a new psychoactive substance in seized material: the synthetic opioid N-phenyl-N-[1-(2-phenethyl)piperidin-4-yl]prop-2-enamide (Acrylfentanyl)

Drug Testing and Analysis

Volumn 9, Issue 3, 2017, Pages 415-422

  Breindahl, Torben ^a   Kimergård, Andreas ^b   Andreasen, Mette Findal ^c   Pedersen, Daniel Sejer ^d  

^a AALBORG UNIVERSITY   (Denmark)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c AARHUS UNIVERSITY   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

acrylfentanyl; acryloylfentanyl; fentanyl analogue; identification; new psychoactive substances; seizure

Indexed keywords

ANESTHETICS; GAS CHROMATOGRAPHY; IONIZATION OF GASES; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; SPECTRUM ANALYSIS;

ACRYLOYLFENTANYL; ALSO KNOWN AS ACRYLOYLFENTANYL; DRUG ANALYSIS; ENAMIDES; FENTANYL ANALOGS; FENTANYLS; IDENTIFICATION; NEW PSYCHOACTIVE SUBSTANCE; OPIOIDS; SEIZURE;

NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

1 (2 PHENETHYL)PIPERIDIN 4 ONE; FENTANYL DERIVATIVE; N PHENYL 1 (2 PHENYLETHYL)PIPERIDIN 4 AMINE; OPIOID N PHENYL N [1 (2 PHENETHYL)PIPERIDIN 4 YL] PROP 2 ENAMIDE; PIPERIDINE DERIVATIVE; UNCLASSIFIED DRUG; DESIGNER DRUG; FENTANYL; NARCOTIC ANALGESIC AGENT; PSYCHOTROPIC AGENT;

ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG IDENTIFICATION; DRUG IMPURITY; DRUG STRUCTURE; INFRARED SPECTROSCOPY; LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; MATRIX ASSISTED LASER IONIZATION ORBITRAP MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POWDER; QUADRUPOLE MASS SPECTROMETRY; QUANTITATIVE ANALYSIS; TIME OF FLIGHT MASS SPECTROMETRY; ANALOGS AND DERIVATIVES; CHEMISTRY; INFRARED SPECTROPHOTOMETRY; MATRIX-ASSISTED LASER DESORPTION-IONIZATION MASS SPECTROMETRY;

ANALGESICS, OPIOID; CHROMATOGRAPHY, LIQUID; DESIGNER DRUGS; FENTANYL; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; MAGNETIC RESONANCE SPECTROSCOPY; PSYCHOTROPIC DRUGS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SPECTROPHOTOMETRY, INFRARED;

EID: 84983341507     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.2046     Document Type: Article

References (40)

1. EMCDDA (European Monitoring Centre for Drugs and Drug Addiction). European Drug Report 2016. Trends and Developments. Available at: http://www.emcdda.europa.eu/edr2016 [4 July 2016].
2. EMCDDA (European Monitoring Centre for Drugs and Drug Addiction). New psychoactive substances in Europe: An update from the EU Early Warning System. Available at: http://www.emcdda.europa.eu/publications/2015/new-psychoactive-substances [4 July 2016].
3. S. D. Brandt, L. A. King, M. Evans-Brown. The new drug phenomenon. Drug Test. Anal. 2014, 6, 587.
4. UNODC (United Nations Office on Drug and Crime). The challenge of new psychoactive substances Available at: https://www.unodc.org/documents/scientific/NPS_2013_SMART.pdf [4 July 2016].
5. Carroll County Health Department. Alert: Counterfeit Street Pills and fentanyl-Related Overdoses in Carroll County. Available at: http://cchd.maryland.gov/alert-counterfeit-street-pills-and-fentanyl-related-overdoses-in-carroll-county/ [4 July 2016].
6. WEDINOS (Welsh Emerging Drugs and Identification of Novel Substances Project). Sample W005255. Available at: http://wedinos.org/db/samples/ [4 July 2016].
7. P. Quintana, M. Ventura. Ocfentanil: a novel fentanyl derivative detected as an adulterant of heroin. 2016. Poster presented at IV International Conference on Novel Psychoactive Substances. Budapest, 30–31 May, 2016.
8. T. C. Kram, D. A. Cooper, A. C. Allen. Behind the identification of China White. Anal. Chem. 1981, 53, 1379A.
9. G. L. Henderson. Designer drugs: past history and future prospects. J. Forensic Sci. 1988, 33, 569.
10. G. L. Henderson. Fentanyl-related deaths: demographics, circumstances, and toxicology of 112 cases. J. Forensic Sci. 1991, 36, 422.
11. J. Tuusov, K. Vals, M. Tõnisson, A. Riikoja, G. Denissov, M. Väli. Fatal poisoning in Estonia 2000–2009. Trends in illegal drug-related deaths. J. Forensic Leg. Med. 2012, 20, 51.
12. A. Talu, K. Rajaleid, K. Abel-Ollo, K. Rüütel, M. Rahu, T. Rhodes, L. Platt, N. Bobrova, A. Uusküla. HIV infection and risk behaviour of primary fentanyl and amphetamine injectors in Tallinn, Estonia: implications for intervention. Int. J. Drug Pol. 2009, 21, 56.
13. EMCDDA (European Monitoring Centre for Drugs and Drug Addiction) – Europol. Acetylfentanyl. EMCDDA–Europol Joint Report on a new psychoactive substance: N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl] acetamide (acetylfentanyl). Available at: http://www.emcdda.europa.eu/publications/joint-reports/acetylfentanyl [4 July 2016].
14. CCENDU (Canadian Centre on Substance Misuse). CCENDU Bulletin. Novel synthetic opioids in Counterfeit Pharmaceuticals and other illicit street drugs. Available at: http://www.ccsa.ca/Resource%20Library/CCSA-CCENDU-Novel-Synthetic-Opioids-Bulletin-2016-en.pdf [4 July 2016].
15. Office of the Chief Coroner. Illicit Drug Overdose Deaths in BC January 1, 2007 – May 31, 2016. Available at: http://www2.gov.bc.ca/assets/gov/public-safety-and- emergency-services/death-investigation/statistical/illicit-drug.pdf.[4 July 2016]
16. A. Amlani, G. McKee, N. Khamis, G. Raghukumar, E. Tsang, J. A. Buxton. Why the FUSS (Fentanyl Urine Screen Study)? A cross-sectional survey to characterize an emerging threat to people who use drugs in British Columbia, Canada. Harm Reduct.J. 2015, 12, 54.
17. A. B. Melent'ev, S. S. Kataev, O. N. Dvorskaya. Identification and analytical properties of acetyl fentanyl metabolites. J. Analyt. Chem. 2015, 70, 240.
18. WHO (World Health Organization). Acetylfentanyl. Critical Review Report. Agenda item 5.2. Expert Committee on Drug Dependence. Thirty-seventh Meeting, Geneva, 2015. Available at: http://www.who.int/medicines/access/controlled-substances/5.2_Acetylfentanyl_CRev.pdf [4 July 2016].
19. M. J. Lozier, M. Boyd, C. Stanley, L. Ogilvie, E. King, C. Martin, L. Lewis. Acetyl fentanyl, a novel fentanyl analog, causes 14 overdose deaths in Rhode Island, March–May 2013. J. Med. Toxicol. 2015, 11, 208.
20. I. M. McIntyre, A. Trochta, R. D. Gary, M. Malamatos, J. R. Lucas. An acute acetyl fentanyl fatality: a case report with postmortem concentrations. J. Analyt. Toxicol. 2015, 39, 490 Erratum in: J. Anal. Toxicol. 2016, 88.
21. DEA (Drug Enforcement Administration). Office of Diversion Control. Drug & Chemical Evaluation Section. Acetyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) (DEA/OD/ODE, July 2015). Available at: http://www.deadiversion.usdoj.gov/drug_chem_info/acetylfentanyl.pdf [4 July 2016].
22. S. M. Cunningham, N. A. Haikal, J. C. Kraner. Fatal intoxication with acetyl fentanyl. J. Forensic Sci. 2015, 61, S276.
23. A. Helander, M. Bäckberg, O. Beck. Intoxications involving the fentanyl analogs acetylfentanyl, 4-methoxybutyrfentanyl and furanylfentanyl: results from the Swedish STRIDA project. Clin. Toxicol. 2016, 54, 324.
24. J. B. Cole, J. F. Dunbar, S. A. McIntire, W. E. Regelmann, T. M. Slusher. Butyrfentanyl overdose resulting in diffuse alveolar hemorrhage. Pediatrics. 2015, 135, e740.
25. M. Bäckberg, O. Beck, K.-H. Jönsson, A. Helander. Opioid intoxications involving butyrfentanyl, 4-fluorobutyrfentanyl, and fentanyl from the Swedish STRIDA project. Clin. Toxicol. 2015, 53, 609.
26. J. Mounteney, I. Giraudon, G. Denissov, P. Griffiths. Fentanyls: Are we missing the signs? Highly potent and on the rise in Europe. Int. J. Drug Pol. 2015, 26, 626.
27. WEDINOS (Welsh Emerging Drugs and Identification of Novel Substances Project). Sample W004251. Available at: http://wedinos.org/db/samples/ [4 July 2016].
28. L. J. Marinetti, B. J. Ehlers. A series of forensic toxicology and drug seizure cases involving illicit fentanyl alone and in combination with heroin, cocaine or heroin and cocaine. J. Anal. Toxicol. 2014, 38, 592.
29. V. Coopman, P. Blanckaert, G. Van Parys, S. Van Calenbergh, J. Cordonnier. A case of acute intoxication due to combined use of fentanyl and 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide (U-47700). Forensic Sci Int. 2016, 266, 68.
30. R. Telving, J. B. Hasselstrøm, M. F. Andreasen. Targeted toxicological screening for acidic, neutral and basic substances in postmortem and antemortem whole blood using simple protein precipitation and UPLC-HR-TOF-MS. J. Forensic Sci. 2016, 266, 453.
31. Anonymous author. A description of the synthesis of fentanyl. Available at: https://www.erowid.org/archive/rhodium/chemistry/fentanyl.html [24 June 2016].
32. H. Ohta, S. Suzuki, K. Ogasawara. Studies on fentanyl and related compounds IV. Chromatographic and spectrometric discrimination of fentanyl and its derivatives. J. Anal. Toxicol. 1999, 23, 280.
33. C. A. Valdez, R. N. Leif, B. P. Mayer. An efficient, optimized synthesis of fentanyl and related analogs. PLoS One. 2014, 9, e108250.
34. R. K. Nishikawa, S. C. Bell, J. C. Kraner, P. S. Callery. Potential biomarkers of smoked fentanyl utililizing pyrolysis gas chromatography-mass spectrometry. J. Anal. Toxicol. 2009, 33, 418.
35. M. Thevis, H. Geyer, D. Bahr, W. Schänzer. Identification of fentanyl, alfentanil, sufentanil, remifentanil and their major metabolites in human urine by liquid chromatography/tandem mass spectrometry for doping control purposes. Eur. J. Mass Spectrom. 2005, 11, 419.
36. B. E. Maryanoff, E. J. Simon, T. Gioannini, H. Gorissen. Potential affinity labels for the opiate receptor based on fentanyl and related compounds. J. Med. Chem. 1982, 25, 913.
37. N. Dong, W. C. Lu, N. Y. Chen, Y. C. Zhu, K. X. Chen. Using support vector classification for SAR of fentanyl derivatives. Acta Pharmacol. Sin. 2005, 26, 107.
38. M. Y. H. Essawi. Fentanyl analogues with a modified propanamido group as potential affinity labels: synthesis and in vivo activity. Pharmazie. 1999, 54, 307.
39. Y.-Q. Zhu, B.-L. Ge, S.-N. Fang, Y.-C. Zhu, Q.-Y. Dai, Q.-Y. Tan, Z.-M. Huang, X.-J. Chen. Studies on potent analgesics. I. Synthesis and analgesic activity of fentanyl derivatives. Yaoxue Xuebao. 1981, 16, 199.
40. B.-T. Wang, J. M. Colby, A. H. B. Wu, K. L. Lynch. Cross-reactivity of acetylfentanyl and risperidone with a fentanyl immunoassay. J. Analytic. Toxicol. 2014, 38, 672.